Mosaic Biosciences, Inc. — Form D
Mosaic Biosciences, Inc. of BOULDER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2011-07-20. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-07-20
- Form: D
- Accession: 0001526054-11-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $1.0M
- Amount sold: $1.0M
- Investors: 7
- Date of first sale: 2011-07-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-163239
Issuer
- Name: Mosaic Biosciences, Inc.
- CIK: 0001526054
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 2830 Wilderness Place, BOULDER, CO, 80301
- Phone: 720-535-8427
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Rob Capone | Director | St. Louis, MO |
| Eric Furfine | Director | Watertown, MA |
| Jeanette Welsh | Director | Boulder, CO |
| Dan Mitchell | Director | Boulder, CO |
| Martin Stanton | Director | Boulder, CO |
| Martin Stanton | Executive Officer | Boulder, CO |
| Mark Lupa | Director | Boulder, CO |
| Guy Katsav | Director | Manassas, VA |
| Augustine Lawlor | Director | South San Francisco, CA |
| NASSIM USMAN | Director | South San Francisco, CA |
Other filings by this issuer (2)
More